{"id":"W2592367943","doi":"10.2147/hiv.s108756","title":"Response by gender of HIV-1-infected subjects treated with abacavir/lamivudine plus atazanavir, with or without ritonavir, for 144 weeks","year":2017,"lang":"en","type":"article","venue":"HIV/AIDS - Research and Palliative Care","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"University Health Network","funders":"ViiV Healthcare; GlaxoSmithKline; Bristol-Myers Squibb","keywords":"Ritonavir; Atazanavir; Abacavir; Medicine; Adverse effect; Lamivudine; Internal medicine; Human immunodeficiency virus (HIV); Viral load; Gastroenterology; Virology; Antiretroviral therapy; Virus","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005005694,0.0003628985,0.0006021529,0.0002148562,0.0001995477,0.0002736045,0.0001636537,0.0003061012,0.002703093],"category_scores_gemma":[0.0006680004,0.0001821874,0.0003826976,0.0001201287,0.0001831286,0.000215061,0.0001333718,0.0003056833,0.0005781223],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001860559,"about_ca_system_score_gemma":0.0001786819,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003434974,"about_ca_topic_score_gemma":0.0005490114,"domain_scores_codex":[0.9997664,0.00008030857,0.00001539967,0.00004686033,0.00003691196,0.00005411356],"domain_scores_gemma":[0.9996201,0.00008450283,0.0001012357,0.00001989371,0.00003145486,0.0001427036],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1730719,0.004132216,0.7292509,0.0001652232,0.0007451962,0.0006074347,0.0003572279,0.0005818268,0.04501272,0.00008274108,0.001403889,0.04458873],"study_design_scores_gemma":[0.005810679,0.03971548,0.9477633,0.00003102719,0.0002974737,0.0007135013,0.0001791673,0.0009770583,0.003005188,0.0001159537,0.001367757,0.00002339426],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9989702,0.0002769737,0.00004843758,0.00002850351,0.00001505252,0.00003225113,0.0002337356,0.000003964341,0.0003910861],"genre_scores_gemma":[0.9990889,0.00007228155,0.00006035798,0.00008763769,0.00001908978,0.00003003091,0.0002588796,0.000001882075,0.0003810447],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002703093,"threshold_uncertainty_score":0.009042799,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0964436235399211,"score_gpt":0.3903596400252832,"score_spread":0.2939160164853621,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}